Cite
HARVARD Citation
Brodiazhenko, T. et al. (2022). Synthetic oxepanoprolinamide iboxamycin is active against Listeria monocytogenes despite the intrinsic resistance mediated by VgaL/Lmo0919 ABCF ATPase. JAC-antimicrobial resistance. 4 (3), p. . [Online].